Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.16341
Abstract: Abstract Background Rabacfosadine (RAB, Tanovea‐CA1) is a novel chemotherapy agent conditionally approved for the treatment of lymphoma in dogs. Hypothesis/Objectives To determine the efficacy and safety of RAB in dogs with lymphoma. Animals One hundred… read more here.
Keywords: dogs lymphoma; placebo; rab; rabacfosadine ... See more keywords
Circulating Endocannabinoids in Canine Multicentric Lymphoma Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Veterinary Science"
DOI: 10.3389/fvets.2022.828095
Abstract: The endocannabinoid system is increasingly being implicated in the pathogenesis and progression of various human cancers. Specifically, increased levels of 2-arachidonoylglycerol (2-AG) and oleoythanolamide (OEA) have been demonstrated in human diffuse large B-cell lymphoma (DLBCL)… read more here.
Keywords: multicentric lymphoma; dogs lymphoma; cell lymphoma; pea ... See more keywords
Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Animal Hospital Association"
DOI: 10.5326/jaaha-ms-6878
Abstract: Combination chemotherapy can be an effective option for treating resistant lymphoma in dogs. This retrospective study examined the tolerability and efficacy of the combination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (dacarbazine) (DTIC) in a population of dogs with lymphoma… read more here.
Keywords: chemotherapy; combination; mitoxantrone dtic; combination chemotherapy ... See more keywords